Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
12/15/201610:52AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/13/201610:09AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/13/201610:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
12/13/201610:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/13/201610:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/13/20169:59AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/13/20169:58AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/13/20169:58AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/13/20169:57AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/13/20169:56AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/13/20169:56AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/06/20168:57AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
12/05/20161:45PMBusiness WirePreclinical Data on IMGN632, a Novel CD123-Targeting ADC, Presented at ASH Annual MeetingNASDAQ:IMGNImmunoGen Inc
11/11/20167:00AMBusiness WireImmunoGen to Present Preclinical Data Highlighting Potential of Combining Mirvetuximab Soravtansine with an Immune Checkpoint...NASDAQ:IMGNImmunoGen Inc
11/10/201610:51AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
11/09/201612:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/04/20163:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
11/04/201612:43PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IMGNImmunoGen Inc
11/03/201611:56AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/03/201611:56AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/03/201610:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/03/201610:13AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/03/20168:05AMBusiness WireImmunoGen Announces Preclinical Data Presentations for Two ADCs With Novel IGN Payloads at Upcoming 58th ASH Annual MeetingNASDAQ:IMGNImmunoGen Inc
10/28/20168:45AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IMGNImmunoGen Inc
10/28/20168:45AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IMGNImmunoGen Inc
10/28/20165:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
10/28/20165:30AMBusiness WireImmunoGen Reports Financial Results for Quarter Ended September 30 and Reviews Business HighlightsNASDAQ:IMGNImmunoGen Inc
10/20/201610:38AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/14/20167:30AMBusiness WireImmunoGen, Inc. Announces Conference Call to Discuss its Financial Results for Quarter Ended September 30NASDAQ:IMGNImmunoGen Inc
10/03/20169:40AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN